Long-term immunosuppression of rabbits through oral tacrolimus administration

Abstract

Background: The absence of well-established immunosuppressed rabbit models poses a significant hurdle in xenograft experiments. Tacrolimus has been identified as a highly promising immunosuppressive agent for rabbits. However, determining the optimal dosage and route of administration to minimize toxicity while maintaining efficacy remains challenging.

Methods: In this study, we investigated the effect of orally administered tacrolimus in rabbits, with an aim to achieve a whole blood target trough level of 3–10 ng/mL, and looked at signs of tissue rejection after the transplantation of a human nerve conduit to repair a severed fibular nerve. An oral dosage range of 0.25–1.5 mg/kg/d was studied for up to 1 year in 63 New Zealand rabbits.

Results: We demonstrated the feasibility of long-term grafting in rabbits while maintaining safe immunosuppression, with side effects mainly limited to diarrhea. Customizing the administered dose proved crucial for graft efficacy and low toxicity, which translated into 100% individual survival. We suggest an oral tacrolimus dose of 1.0–1.5 mg/kg depending on individual heterogeneity and recommend to implement a close therapeutic drug monitoring in the rabbits to maintain a whole blood tacrolimus trough level within the range of 5–12 ng/mL, as levels below 5 ng/mL showed signs of inflammation in the graft.

Conclusion: The oral administration of tacrolimus enabled efficient immunosuppression of rabbits over a 1-year period without significant side effects or loss of animals.

Keywords

adverse effect / blood level / immunosuppression / nerve graft / rabbit / tacrolimus

References

[1] Giessler GA, Gades NM, Friedrich PF, Bishop AT. Severe tacrolimus toxicity in rabbits. Exp Clin Transplant. 2007; 5: 590-595.

[2] Mapara M, Thomas BS, Bhat KM. Rabbit as an animal model for experimental research. Dent Res J (Isfahan). 2012; 9: 111-118.

[3] Piekoszewski W, Chow FS, Jusko WJ. Disposition of tacrolimus (FK 506) in rabbits. Role of red blood cell binding in hepatic clearance. Drug Metab Dispos. 1993; 21: 690-698.

[4] Liu Y, Zhang Y, Ding Y, et al. Successful orthotopic uterine allotransplantation in a rabbit model using aorta and cava anastomoses: a short-term viability study. Arch Gynecol Obstet. 2020; 301: 533-544.

[5] Kino T, Hatanaka H, Miyata S, et al. FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. J Antibiot (Tokyo). 1987; 40(9): 1256-1265.

[6] Bechstein WO, Malaise J, Saudek F, et al. Efficacy and safety of tacrolimus compared with cyclosporine microemulsion in primary simultaneous pancreas-kidney transplantation: 1-year results of a large multicenter trial. Transplantation. 2004; 77(8): 1221-1228.

[7] Ekberg H, Tedesco-Silva H, Demirbas A, et al. Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med. 2007; 357(25): 2562-2575.

[8] Treede H, Klepetko W, Reichenspurner H, et al. Tacrolimus versus cyclosporine after lung transplantation: a prospective, open, randomized two-center trial comparing two different immunosuppressive protocols. J Heart Lung Transplant. 2001; 20: 511-517.

[9] Ochiai T, Nagata M, Nakajima K, et al. Studies of the effects of FK506 on renal allografting in the beagle dog. Transplantation. 1987; 44(6): 729-733.

[10] Ochiai T, Nakajima K, Nagata M, Hori S, Asano T, Isono K. Studies of the induction and maintenance of long-term graft acceptance by treatment with FK506 in heterotopic cardiac allotransplantation in rats. Transplantation. 1987; 44(6): 734-738.

[11] Qi S, Xu D, Peng J, et al. Effect of tacrolimus (FK506) and sirolimus (rapamycin) mono- and combination therapy in prolongation of renal allograft survival in the monkey. Transplantation. 2000; 69: 1275-1283.

[12] Tanaka Isomura E, Yoshitomi K, Hamaguchi M, Yamamoto YE, Kogo M. Transplantation of vascularized submandibular gland in dogs. J Oral Maxillofac Surg. 2006; 64: 1561-1565.

[13] Vossen M, Majzoub RK, Edelstein J, et al. Bone quality in swine composite tissue allografts: effects of combination immunotherapy. Transplantation. 2005; 80(4): 487-493.

[14] Sigal NH, Dumont FJ. Cyclosporin a, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction. Annu Rev Immunol. 1992; 10: 519-560.

[15] Filler G, Grygas R, Mai I, et al. Pharmacokinetics of tacrolimus (FK 506) in children and adolescents with renal transplants. Nephrol Dial Transplant. 1997; 12: 1668-1671.

[16] Almansoori AA, Khentii N, Ju KW, Kim B, Kim SM, Lee JH. FK506 immunosuppression for submandibular salivary gland allotransplantation in rabbit. J Korean Assoc Oral Maxillofac Surg. 2020; 46: 197-203.

[17] Takahashi T, Sato M, Toyoda E, et al. Rabbit xenogeneic transplantation model for evaluating human chondrocyte sheets used in articular cartilage repair. J Tissue Eng Regen Med. 2018; 12: 2067-2076.

[18] Lee KW, Kim TH, Lee JB, et al. Reduced variability in tacrolimus pharmacokinetics following intramuscular injection compared to oral administration in cynomolgus monkeys: investigating optimal dosing regimens. J Pharmacol Sci. 2019; 139: 65-71.

[19] Rasmussen F. Tissue damage at the injection site after intramuscular injection of drugs. Vet Sci Commun. 1978; 2: 173-182.

[20] Ikebe S, Masumi S, Yano H, Fukunaga T, Shimizu K, Shin S. Immunosuppressive effect of tacrolimus (FK-506). Bone xenografts in rabbits. Acta Orthop Scand. 1996; 67: 389-392.

[21] Giessler GA, Zobitz M, Friedrich PF, Bishop AT. Host-derived neoangiogenesis with short-term immunosuppression allows incorporation and remodeling of vascularized diaphyseal allogeneic rabbit femur transplants. J Orthop Res. 2009; 27: 763-770.

[22] Kremer T, Giessler GA, Friedrich PF, Willems WF, Giusti G, Bishop AT. Surgical angiogenesis with short-term immunosuppression maintains bone viability in rabbit allogenic knee joint transplantation. Plast Reconstr Surg. 2013; 131: 148-157.

[23] Qin H, Janowski M, Pearl MS, et al. Rabbit model of human gliomas: implications for intra-arterial drug delivery. PLoS One. 2017; 12: e0169656.

[24] Saso S, Petts G, Chatterjee J, et al. Uterine allotransplantation in a rabbit model using aorto-caval anastomosis: a long-term viability study. Eur J Obstet Gynecol Reprod Biol. 2014; 182: 185-193.

[25] Thibodeau A, Galbraith T, Fauvel CM, Khuong HT, Berthod F. Repair of peripheral nerve injuries using a prevascularized cell-based tissue-engineered nerve conduit. Biomaterials. 2022; 280: 121269.

[26] Laverdiere I, Caron P, Couture F, Levesque E, Guillemette C. A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for monitoring drug exposure in hematopoietic stem cell transplant recipients. J Chromatogr B Analyt Technol Biomed Life Sci. 2012; 885: 131-137.

[27] Vafadari R, Hesselink DA, Cadogan MM, Weimar W, Baan CC. Inhibitory effect of tacrolimus on p38 mitogen-activated protein kinase signaling in kidney transplant recipients measured by whole-blood phosphospecific flow cytometry. Transplantation. 2012; 93: 1245-1251.

[28] Yanchar NL, Riegel TM, Martin G, Fedorak RN, Kneteman NM, Sigalet DL. Tacrolimus (FK506)—its effects on intestinal glucose transport. Transplantation. 1996; 61: 630-634.

[29] Melillo A. Rabbit clinical pathology. J Exot Pet Med. 2007; 16: 135-145.

[30] Washington I, Van Hoosier G. Clinical biochemistry and hematology. In: Suckow M, Stevens K, Wilson R, eds. Laboratory Rabbit, Guinea Pig, Hamster, and Other Rodents. Elsevier Academic Press; 2012: 57-116.

[31] Hein J, Hartmann K. Reference ranges for laboratory parameters in rabbits. Tierarztl Prax Ausg K Kleintiere Heimtiere. 2003; 31: 321-328.

[32] Shousha SM, Mahmoud MA, Hameed K. Some Haemato-biochemical values in white New Zealand rabbits. IOSR J Agric Vet Sci. 2017; 10: 40-44.

[33] Kershner RP, Fitzsimmons WE. Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantation. Transplantation. 1996; 62: 920-926.

[34] Fujino Y, Mochizuki M, Chan CC, et al. FK506 treatment of S-antigen induced uveitis in primates. Curr Eye Res. 1991; 10: 679-690.

[35] Kemper MJ, Sparta G, Laube GF, Miozzari M, Neuhaus TJ. Neuropsychologic side-effects of tacrolimus in pediatric renal transplantation. Clin Transpl. 2003; 17: 130-134.

[36] Birdwell KA, Decker B, Barbarino JM, et al. Clinical Pharmacogenetics implementation consortium (CPIC) guidelines for CYP3A5 genotype and tacrolimus dosing. Clin Pharmacol Ther. 2015; 98(1): 19-24.

[37] Turner PV, Brabb T, Pekow C, Vasbinder MA. Administration of substances to laboratory animals: routes of administration and factors to consider. J Am Assoc Lab Anim Sci. 2011; 50: 600-613.

[38] Black DM, Gilardi KV, Hamilton LP, et al. Hematologic and biochemistry reference values for the endangered riparian brush rabbit (Sylvilagus bachmani riparius). J Wildl Dis. 2009; 45: 491-496.

RIGHTS & PERMISSIONS

2025 The Author(s). Animal Models and Experimental Medicine published by John Wiley & Sons Australia, Ltd on behalf of The Chinese Association for Laboratory Animal Sciences.